Month: September 2021

MediciNova to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

Written by Customer Service on September 3, 2021. Posted in Public Companies.

LA JOLLA, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova will participate in the virtual Morgan Stanley 19th Annual Global Healthcare Conference which will be held from September 9 – 15, 2021. Yuichi Iwaki, MD, PhD, President and Chief Executive Officer, and Geoffrey O’Brien, JD/MBA, Vice President and Executive Officer, will be available for one-on-one meetings at this conference and investors may request a one-on-one meeting through Morgan Stanley. About MediciNova MediciNova, Inc. is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for inflammatory, fibrotic,...

Kayne Anderson NextGen Energy & Infrastructure Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at August 31, 2021

Written by Customer Service on September 3, 2021. Posted in Public Companies.

HOUSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) — Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of August 31, 2021. As of August 31, 2021, the Fund’s net assets were $414 million and its net asset value per share was $8.77. As of August 31, 2021, the Fund’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 505% and the Fund’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 369%. Kayne Anderson NextGen Energy & Infrastructure, Inc.Statement of Assets and LiabilitiesAugust 31, 2021(Unaudited) (in...

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at August 31, 2021

Written by Customer Service on September 3, 2021. Posted in Public Companies.

HOUSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of August 31, 2021. As of August 31, 2021, the Company’s net assets were $1.1 billion, and its net asset value per share was $8.89. As of August 31, 2021, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 491% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 371%.Kayne Anderson Energy Infrastructure Fund, Inc.Statement of Assets and LiabilitiesAugust 31, 2021(Unaudited) (in...

Logiq Announces Issuance of Common Stock

Written by Customer Service on September 3, 2021. Posted in Public Companies.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) — Logiq, Inc. (NEO: LGIQ) (the “Company” or “Logiq”), a global provider of award-winning e-commerce and fintech solutions, has announced that it has granted and issued a total of 1,242,187 common stock under its equity incentive plan to certain employees and consultants of the Company (the “Stock Awards”). All of the above mentioned Stock Awards were issued at a deemed price of C$5.20 per share pursuant to a Registration Statement on Form S-8 under the U.S. Securities Act of 1933, as amended. 32,000 of the Stock Awards were issued to Brent Suen, the President of the Company, and 100,000 of the Stock Awards were issued to Haig Newton, the President of the Company’s DataLogiq division. The Stock Awards...

MJardin Announces Executive Team Changes

Written by Customer Service on September 3, 2021. Posted in Public Companies.

TORONTO, Sept. 02, 2021 (GLOBE NEWSWIRE) — MJardin Group, Inc. (CSE: MJAR) (OTCQX: MJARF) (the “Company” or “MJardin”), a leader in premium curated cannabis production and distribution announces the following executive changes. Effective immediately, Pat Witcher has resigned as the Company’s Chief Executive Officer to pursue other interests. The board of directors (the “Board”) and management of the Company thank Pat for his years of service to MJardin during the Company’s formative years, and the many initiatives he led on behalf of the Company. Pat will remain as a director of MJardin where he will continue to support the Company during its previously announced restructuring process. The Board has appointed Mr. Anthony Dutton, a current MJardin board member, as interim Chief Executive Officer of the Company while it completes...

Oxus Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering

Written by Customer Service on September 3, 2021. Posted in Public Companies.

Almaty, Kazakhstan , Sept. 02, 2021 (GLOBE NEWSWIRE) — Oxus Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 15,000,000 units, at a price of $10.00 per unit. The units are expected to commence trading on September 3, 2021 on the Nasdaq Capital Market under the symbol “OXUSU”. Each unit consists of one Class A ordinary share and one redeemable warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the Nasdaq Capital Market under the symbols “OXUS” and “OXUSW”, respectively. EarlyBirdCapital, Inc. and Sova Capital Limited are serving as the joint book-running managers of the offering....

Plastic Containers Market to Worth USD 82.00 Billion Forecast [2021-2028]; Expansion of Greiner Packaging Bottle Range to Fortify Market, Report by Fortune Business Insights™

Written by Customer Service on September 3, 2021. Posted in Mergers And Acquisitions.

Top companies covered in plastic containers market report are ALPLA (Hard, Austria), Alpha Packaging (Missouri, U.S.), Amcor (Zurich, Switzerland), Plastipak Packaging (Michigan, U.S.), Graham Packaging (Pennsylvania, U.S.), RPC (Georgia, U.S.), Berry Plastics (Indiana, U.S.), Greiner Packaging (Kremsmunster, Austria), Silgan Holdings Incorporated (Connecticut, U.S.), CKS Packaging Incorporated (Atlanta, U.S.), Fortex-Fortiflex (San Juan, Puerto Rico), Altium Packaging (Georgia, U.S.), Polytainers (Ontario, Canada), Airlite Plastics (Omaha, U.S.), other key players profiled Pune, India, Sept. 02, 2021 (GLOBE NEWSWIRE) — The global plastic containers market size is expected to reach USD 82.00 billion in 2028, exhibiting a CAGR of 5.0% during the forecast period. The growing demand for rigid packaging from food and beverage manufacturers...

Medical Drone Market to Hit $1,410.9 Mn Forecast [2021-2028]; Increased Demand for Contactless Devices to Bode Well for This Industry, Report by Fortune Business Insights™

Written by Customer Service on September 2, 2021. Posted in Mergers And Acquisitions.

Key players covered in the medical drone market are Zipline Inc. (San Francisco, United States), Volocopter GmbH (Bruchsal, Germany), Volansi Inc. (San Francisco, United States), Matternet Inc. (Mountain View, United States), Manna Drone Delivery Inc. (Dublin, Ireland) , Flytrex Aviation Ltd. (Tel Aviv, Israel), Flirtey Holdings Inc. (Reno, United States), Vayu Inc. (Ypsilanti, United States), Skyports Ltd. (Billericay, United Kingdom), Ebre Drone LLC (Tarragona, Spain), Swoop Aero Pty. Ltd. (Docklands, Australia), Skyfarer Ltd. (Coventry, United Kingdom), and more players profiled Pune, India, Sept. 02, 2021 (GLOBE NEWSWIRE) — The global medical drone market size is expected to gain momentum by reaching USD 1,410.9 million by 2028 from USD 254.7 million in 2021 while exhibiting an impressive CAGR of 27.70% between 2021 to 2028....

Supernus Announces Qelbree™ sNDA for Adult Indication Accepted for Review by FDA

Written by Customer Service on September 2, 2021. Posted in Public Companies.

ROCKVILLE, Md., Sept. 02, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the U.S. Food and Drug Administration (FDA) has acknowledged it has received the supplemental new drug application (sNDA) for Qelbree (viloxazine extended-release capsules) for the treatment of attention-deficit hyperactivity disorder (ADHD) in adult patients. The sNDA is now considered filed, with a user fee goal date (PDUFA date) of April 29, 2022. In December 2020, Supernus announced positive topline results from a Phase III study of Qelbree in adults for the treatment of attention deficit hyperactivity disorder (ADHD). The results showed that at a daily dose of up to 600mg,...

CytoDyn to Hold Webcast on September 8 to Discuss Results from mTNBC Trials, HIV BLA Status, and Updates on COVID-19 and NASH Trials

Written by Customer Service on September 2, 2021. Posted in Public Companies.

VANCOUVER, Washington, Sept. 02, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Christopher Recknor, M.D., Chief Operating Officer and Head of Clinical Development, will host an investment community webcast on Wednesday, September 8, 2021. Management will provide an overview of the results from the recently reported data from the mTNBC trials, along with updates on COVID-19 and NASH trials, and the status of the resubmission of the BLA for HIV. Management will provide approximately 60 minutes...

Month: September 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals